YHLO YHLO
  • Home

  • Products

      • CLIA

        • Analyzers

        • Reagents

      • Chemistry

      • TLA

      • LIA

      • ESR

  • Pubilcations

      • Autoimmunity

      • Reproductive Health

      • Diabetes

      • Liver Disease

      • Infection

      • COVID-19

      • ESR

      • Others

  • News

      • YHLO News

  • About YHLO

      • Company Profile

      • Milestone

      • Corporate Values

  • Contact us

      • Career

      • Service

Language
  • 简体中文
  • ENGLISH
Search
Pubilcations

Autoimmunity

Reproductive Health

Diabetes

Liver Disease

Infection

COVID-19

ESR

Others

Search
%{tishi_zhanwei}%
  • Home page

2024/06/05

Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies A real-world retrospective study of 537 patients in C.pdf

Learn more

2024/06/05

Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort

Learn more

2024/06/05

Diagnostic and prognostic value of quantitativedetection of antimitochondrial antibodies

Learn more

2024/06/05

Lack of comparability of immunoassays for rheumatoid factor isotypes

Learn more

2024/06/05

Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome

Learn more

2024/06/05

A predictive model for disease severity among COVID-19 elderly patients based on IgG subtypes and machine learning

Learn more

2024/06/05

Exploring clinical indicator variations in stroke patients with multiple risk factors focus on hypertension and inflammatory reactions

Learn more

2024/06/05

Recognition of rare antinuclear antibody patterns based on a novel attention-based enhancement framework

Learn more

2024/06/05

Human Leucocyte Antigen Alleles and Haplotypes and Their Associations With Antinuclear Antibodies Features in Chinese Patients With Primary Biliary Cirrhosis

Learn more

2024/05/29

Publications 2024.05

Learn more
< 123 >
YHLO
  • Home

  • Products

    • CLIA

      • Analyzers

      • Reagents

    • Chemistry

    • TLA

    • LIA

    • ESR

  • Pubilcations

    • Autoimmunity

    • Reproductive Health

    • Diabetes

    • Liver Disease

    • Infection

    • COVID-19

    • ESR

    • Others

  • News

    • YHLO News

  • About YHLO

    • Company Profile

    • Milestone

    • Corporate Values

  • Contact us

    • Career

    • Service

Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China

Tel: +86 755 26601910

Email: marketing@szyhlo.com

facebook youtube instagram linkedin wechat wechat

Copyright© 2024 Shenzhen YHLO Biotech Co., Ltd.

Powered by 300.cn | SEO | Business License 

Email

8

Email

marketing@szyhlo.com

Tel

9

Tel

+86 755 26601910